Consequences of the COVID-19 Lockdown on Health and Well-being of Patients With Parkinson Disease and Post-stroke
NCT ID: NCT04535297
Last Updated: 2020-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
198 participants
OBSERVATIONAL
2020-05-10
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Remote Cognitive Intervention in Patients With Parkinson's Disease During the COVID-19 Pandemic
NCT05476302
Computer-based Cognitive Training for Parkinson Disease
NCT01121627
Self-Management Behaviors of Arabs and Jews With Parkinson's Disease and Their Associations With Health Outcomes
NCT05209698
Perception of Affordances and Obstacle Crossing in People With Parkinson's Disease and Healthy Adults
NCT06932679
Socio-Clinical Factors Associated With Self-Management in Parkinson's Disease
NCT05211700
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study objectives were: To (1) describe the effects of the COVID-19 social distancing on function, health and well-being of patients with Parkinson's disease or post-stroke, and (2) test the association between the patient activation level and these effects.
Community-living patients with Parkinson's disease or post-stroke were invited to answer an anonymous survey through social media and patient associations. Part 1 included 27 multiple-choice questions regarding current status and changes in function, health, medical care and well-being. Part 2 consisted of the Patient Activation Measure, describing people's knowledge, skill, and confidence in managing their own health.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exposure
Exposure to social distancing due to COVID-19
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Live in the community
* If a family member or caregiver completed the survey, we asked them to answer in reference to the patient.
Exclusion Criteria
* hospitalization in the last 3 months.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Haifa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Galit Yogev-Seligmann
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Galit Yogev-Seligmann
Role: PRINCIPAL_INVESTIGATOR
University of Haifa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Galit Yogev-Seligmann
Haifa, Please Select..., Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
203/20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.